UniProt ID | FBXL3_HUMAN | |
---|---|---|
UniProt AC | Q9UKT7 | |
Protein Name | F-box/LRR-repeat protein 3 | |
Gene Name | FBXL3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 428 | |
Subcellular Localization | Nucleus . Cytoplasm . Predominantly nuclear. | |
Protein Description | Substrate-recognition component of the SCF(FBXL3) E3 ubiquitin ligase complex involved in circadian rhythm function. Plays a key role in the maintenance of both the speed and the robustness of the circadian clock oscillation. [PubMed: 17463251] | |
Protein Sequence | MKRGGRDSDRNSSEEGTAEKSKKLRTTNEHSQTCDWGNLLQDIILQVFKYLPLLDRAHASQVCRNWNQVFHMPDLWRCFEFELNQPATSYLKATHPELIKQIIKRHSNHLQYVSFKVDSSKESAEAACDILSQLVNCSLKTLGLISTARPSFMDLPKSHFISALTVVFVNSKSLSSLKIDDTPVDDPSLKVLVANNSDTLKLLKMSSCPHVSPAGILCVADQCHGLRELALNYHLLSDELLLALSSEKHVRLEHLRIDVVSENPGQTHFHTIQKSSWDAFIRHSPKVNLVMYFFLYEEEFDPFFRYEIPATHLYFGRSVSKDVLGRVGMTCPRLVELVVCANGLRPLDEELIRIAERCKNLSAIGLGECEVSCSAFVEFVKMCGGRLSQLSIMEEVLIPDQKYSLEQIHWEVSKHLGRVWFPDMMPTW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | GRDSDRNSSEEGTAE CCCCCCCCCCCCCHH | 39.77 | 22210691 | |
13 | Phosphorylation | RDSDRNSSEEGTAEK CCCCCCCCCCCCHHH | 43.12 | 29759185 | |
20 | Ubiquitination | SEEGTAEKSKKLRTT CCCCCHHHHHHCCCC | 66.18 | 23503661 | |
21 | Phosphorylation | EEGTAEKSKKLRTTN CCCCHHHHHHCCCCC | 26.91 | 22210691 | |
26 | Ubiquitination | EKSKKLRTTNEHSQT HHHHHCCCCCCCCCC | 44.39 | 22817900 | |
38 | Ubiquitination | SQTCDWGNLLQDIIL CCCCCHHHHHHHHHH | 33.07 | 21963094 | |
49 | Ubiquitination | DIILQVFKYLPLLDR HHHHHHHHHHHHHCH | 47.20 | 21890473 | |
52 | Ubiquitination | LQVFKYLPLLDRAHA HHHHHHHHHHCHHHH | 27.99 | 22817900 | |
94 | Phosphorylation | ATSYLKATHPELIKQ HHHHHHHHCHHHHHH | 36.05 | 22673903 | |
96 | Ubiquitination | SYLKATHPELIKQII HHHHHHCHHHHHHHH | 33.46 | 21963094 | |
100 | Ubiquitination | ATHPELIKQIIKRHS HHCHHHHHHHHHHCC | 48.33 | 29967540 | |
107 | Phosphorylation | KQIIKRHSNHLQYVS HHHHHHCCCCEEEEE | 29.94 | 29083192 | |
112 | Phosphorylation | RHSNHLQYVSFKVDS HCCCCEEEEEEEECC | 12.38 | 29083192 | |
114 | Phosphorylation | SNHLQYVSFKVDSSK CCCEEEEEEEECCCH | 17.89 | 29083192 | |
116 | Ubiquitination | HLQYVSFKVDSSKES CEEEEEEEECCCHHH | 37.31 | 29967540 | |
119 | Phosphorylation | YVSFKVDSSKESAEA EEEEEECCCHHHHHH | 46.42 | 29083192 | |
120 | Phosphorylation | VSFKVDSSKESAEAA EEEEECCCHHHHHHH | 35.66 | 29083192 | |
121 | Ubiquitination | SFKVDSSKESAEAAC EEEECCCHHHHHHHH | 60.69 | 29967540 | |
169 | Ubiquitination | SALTVVFVNSKSLSS EEEEEEEECCCCCCC | 5.52 | 22817900 | |
172 | Ubiquitination | TVVFVNSKSLSSLKI EEEEECCCCCCCCCC | 50.65 | 23503661 | |
175 | Phosphorylation | FVNSKSLSSLKIDDT EECCCCCCCCCCCCC | 40.49 | 24719451 | |
178 | Ubiquitination | SKSLSSLKIDDTPVD CCCCCCCCCCCCCCC | 46.14 | 21906983 | |
182 | Phosphorylation | SSLKIDDTPVDDPSL CCCCCCCCCCCCCCC | 22.82 | 27067055 | |
190 | Ubiquitination | PVDDPSLKVLVANNS CCCCCCCEEEEECCC | 37.55 | 21906983 | |
199 | Phosphorylation | LVANNSDTLKLLKMS EEECCCHHHHHHHHH | 26.13 | 27067055 | |
201 | Ubiquitination | ANNSDTLKLLKMSSC ECCCHHHHHHHHHCC | 54.59 | 21906983 | |
204 | Ubiquitination | SDTLKLLKMSSCPHV CHHHHHHHHHCCCCC | 47.36 | 22817900 | |
229 | Ubiquitination | QCHGLRELALNYHLL HCCCHHHHHHHHHHC | 5.48 | 21963094 | |
248 | Ubiquitination | LLALSSEKHVRLEHL HHHHCCCCCCCCEEE | 49.72 | 21963094 | |
284 | Phosphorylation | WDAFIRHSPKVNLVM HHHHHHHCCCCCEEE | 19.30 | - | |
321 | Ubiquitination | YFGRSVSKDVLGRVG ECCCCCCHHHHHCCC | 50.10 | 21906983 | |
362 | Phosphorylation | AERCKNLSAIGLGEC HHHHCCCCCCCCCCC | 27.51 | 27251275 | |
372 | Phosphorylation | GLGECEVSCSAFVEF CCCCCEECHHHHHHH | 4.69 | 27251275 | |
374 | Phosphorylation | GECEVSCSAFVEFVK CCCEECHHHHHHHHH | 19.75 | 27251275 | |
381 | Ubiquitination | SAFVEFVKMCGGRLS HHHHHHHHHHCCCHH | 33.52 | 21963094 | |
388 | Phosphorylation | KMCGGRLSQLSIMEE HHHCCCHHHHHHHHH | 27.93 | 26074081 | |
391 | Phosphorylation | GGRLSQLSIMEEVLI CCCHHHHHHHHHHHC | 16.56 | 26074081 | |
403 | Phosphorylation | VLIPDQKYSLEQIHW HHCCCCCCCHHHHHH | 16.92 | 26074081 | |
404 | Phosphorylation | LIPDQKYSLEQIHWE HCCCCCCCHHHHHHH | 32.25 | 26074081 | |
414 | Ubiquitination | QIHWEVSKHLGRVWF HHHHHHHHHHCCCCC | 48.28 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBXL3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBXL3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBXL3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CUL1_HUMAN | CUL1 | physical | 10531035 | |
SKP1_HUMAN | SKP1 | physical | 10531035 | |
BTG1_HUMAN | BTG1 | physical | 22975506 | |
BTG2_HUMAN | BTG2 | physical | 22975506 | |
CRY1_HUMAN | CRY1 | physical | 17463251 | |
CRY2_HUMAN | CRY2 | physical | 17463251 | |
CUL1_HUMAN | CUL1 | physical | 22268729 | |
CRY1_HUMAN | CRY1 | physical | 24085301 | |
CUL1_HUMAN | CUL1 | physical | 24085301 | |
SKP1_HUMAN | SKP1 | physical | 24085301 | |
CRY2_HUMAN | CRY2 | physical | 24085301 | |
RFX2_HUMAN | RFX2 | physical | 26186194 | |
RFX1_HUMAN | RFX1 | physical | 26186194 | |
CRY1_HUMAN | CRY1 | physical | 26186194 | |
CRY2_HUMAN | CRY2 | physical | 27529127 | |
CRY1_HUMAN | CRY1 | physical | 28514442 | |
RFX2_HUMAN | RFX2 | physical | 28514442 | |
RFX1_HUMAN | RFX1 | physical | 28514442 | |
2A5D_HUMAN | PPP2R5D | physical | 28514442 | |
SKP1_HUMAN | SKP1 | physical | 28614300 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...